Comparison of Antiplatelet Monotherapies After Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks

Clopidogrel was superior to aspirin monotherapy in secondary prevention after percutaneous coronary intervention (PCI). The purpose of this study was to evaluate the benefits of clopidogrel across high-risk subgroups This was a post hoc analysis of the HOST-EXAM (Harmonizing Optimal Strategy for Tre...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the American College of Cardiology 2023-10, Vol.82 (16), p.1565-1578
Hauptverfasser:	Yang, Seokhun, Kang, Jeehoon, Park, Kyung Woo, Hur, Seung-Ho, Lee, Nam Ho, Hwang, Doyeon, Yang, Han-Mo, Ahn, Hyo-Suk, Cha, Kwang Soo, Jo, Sang-Ho, Ryu, Jae Kean, Suh, Il-Woo, Choi, Hyun-Hee, Woo, Seong-Ill, Han, Jung-Kyu, Shin, Eun-Seok, Koo, Bon-Kwon, Kim, Hyo-Soo
Format:	Artikel
Sprache:	eng
Schlagworte:	aspirin bleeding clopidogrel ischemic events percutaneous coronary intervention
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!